ClaimsFiler sets Sept. 22 deadline in PROCEPT BioRobotics securities case
ClaimsFiler says investors in PROCEPT BioRobotics shares bought between Feb. 28, 2024, and Feb. 25, 2026, have until Sept. 22, 2026, to apply for lead plaintiff status in a federal securities class action.
ClaimsFiler says investors who bought PROCEPT BioRobotics Corporation shares between Feb. 28, 2024, and Feb. 25, 2026, have until Sept. 22, 2026, to seek lead plaintiff status in a federal securities class action pending in the U.S. District Court for the Northern District of California.
The case is titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691.
According to the shareholder alert, the complaint alleges that PROCEPT and certain executives failed to disclose material information during the class period in violation of federal securities laws. The notice says the allegations include claims that U.S. handpiece sales had materially exceeded procedures in every quarter since the first fiscal quarter of 2023, that the company had accumulated more than 10,000 excess handpiece units in field inventory, that the imbalance would lead to a significant sequential decline in U.S. handpiece unit sales, and that the company would miss annual revenue guidance.
The alert identifies the case as pending in federal court in Northern California. It also says ClaimsFiler is a shareholder information service and provides contact details for investors who want to review their options.
The notice says lawyers at Kahn Swick & Foti, LLC are available to discuss legal options. It does not say how many investors may be affected.
Investors who believe they were covered by the class period may seek lead plaintiff status by the Sept. 22 deadline while the case continues in federal court.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()